期刊名称：JOURNAL OF INFECTION AND CHEMOTHERAPY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The Journal of Infection and Chemotherapy (JIC) publishes original papers, laboratory or clinical, as well as case reports and notes from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Offerings include experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials.
The Journal of Infection and Chemotherapy is the official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.
Related subjects » Internal Medicine - Oncology & Hematology
Abstracted/Indexed in:
Abstracts in Anthropology, Academic OneFile, Academic Search, Biological Abstracts, BIOSIS, CAB Abstracts, CAB International, Chemical Abstracts Service (CAS), ChemWeb, CSA/Proquest, Current Abstracts, Current Contents/Clinical Medicine, EMBASE, Gale, Global Health, Google Scholar, IBIDS, Journal Citation Reports/Science Edition, OCLC, PubMed/Medline, Science Citation Index Expanded (SciSearch), SCOPUS, Summon by Serial Solutions, TOC Premier
Instructions to Authors
Instructions for Authors
General
The Journal of Infection and Chemotherapy (JIC) �official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases �welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models andpharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome. Papers will be received on the understanding that: they have not been published in whole or in part elsewhere, they are subject to review by at least two referees and the Editors, authors agree to editorial revision in regard to the language and contents, and the Editors are responsible for their acceptance and rejection and their order of publication. When relevant, authors should include a statement regarding the ethical aspects of their research.
ManuscriptsManuscripts
Review of manuscripts may be suspended for lack of conformity to the instructions described herein as well as on the basis of poor English, resulting in significant delays in publication. Papers should be typed in 12-point font, with double-line spacing, on A4 paper (21 × 29.7cm) with a margin of at least 3 cm all around. Lines should be numbered consecutively from the title through the references. Four complete copies of the manuscript (including the original) and four sets of figures are to be submitted, with the author retaining a separate copy for reference.
Submission of electronic filesSubmission of electronic files
After the paper is accepted, authors are required to submit the electronic files for the final manuscript including tables and figures. The electronic files should not be sent until changes requested following the review process have been entered and authors have been notified of acceptance for publication. Tables should be created using the table functions of the word-processing program, not spreadsheets.
Prerequisites for publicationPrerequisites for publication
A Certification Form, included in each issue and which also may be downloaded from the journal webpage (http://www.springer.com/journal/10156/), must be signed by all authors and be submitted with the manuscript. Only those who have made a substantial contribution to the work can be designated as authors, and those who have made a smaller contribution should be recognized separately in the Acknowledgments section.
Page chargesPage charges
For original papers, authors are expected to pay a charge, currently JPY 10 000 per page, for all pages exceeding four printed pages. For case reports, notes, committee reports, guidelines, and papers on clinical trials, the same charges apply for all pages exceeding two printed pages. Invited articles are exempt from these charges.
Original papersOriginal papers
Original papers should be concise, not exceeding 3000 words, set out as follows, with each section beginning on a separate page: Cover page, title page, abstract, text, references, tables, legends to figures and illustrations. Editorials and Review articles are considered for publication by invitation. Papers giving minimum inhibitory concentration (MIC) values of drugs without supporting clinical observations should be submitted as Notes.
The cover pageThe cover page
The cover page must provide the following information: (1) title of the article; (2) full name of each author; (3) the departments and institutions to which the work is to be attributed; and (4) the full name, complete address, telephone and fax numbers, and e-mail address of the corresponding author to whom all correspondence will be addressed.
Title pageTitle page
For editorial purposes, the title page should contain the title only, with no authors�names or affiliations appearing.
The abstractThe abstract
The abstract must not exceed 250 words and should consist of very brief statements about each of the main sections, without including extensive experimental details and without using abbreviations. The abstract is to be complete in itself and comprehensible without reference to the text proper.
Key words Key words
Three to six key words should be listed below the abstract for indexing purposes.
The textThe text
The text is to be arranged as follows: (1) Introduction; (2) Patients and methods, or Materials and methods; (3) Results; (4) Discussion; (5) Acknowledgments.
ReferencesReferences
The author is responsible for the accuracy of the references. References must be numbered consecutively in order of appearance in the text (citation-sequence system) and cited in the text using numbers in square brackets on the line, e.g., Ames et al. [1] reported� Only the first six authors are to be listed in a reference, followed by “et al�if there are other coauthors; the complete title; the abbreviated journal name according to Index Medicus; the year of publication; the volume number; and inclusive page numbers. Unpublished observations and personal communications may not be added to the reference list, although written communications may be mentioned by inserting the author and date in the text in parentheses. Information from manuscripts submitted but not yet accepted should be cited in the text as unpublished data. Manuscripts accepted but not yet published can be included in the reference list; the journal should be designated and “in press�added in parentheses. Examples of references are given below.Journal:Tojo M, Yamashita N, Goldmann DA, Pier GB. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis. 1988;157:713�2.Journal article by DOI:Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet. 2009. doi: 10.1016/S0140-6736(09)60879-5.Book:Labischinski H, Maidhof H, Franz M, Krüger D, Sidow T, Giesbrecht P. Biochemical and biophysical investigations into the cause of penicillin-induced lytic death of staphylococci: checking predictions of the murosome model. In: Actor P, Daneo-Moore L, Higgins ML, Salton MRJ, Shockman GD, editors. Antibiotic inhibition of bacterial surface assembly and function. Washington, DC: American Society for Microbiology; 1988. p. 181�57.Tables should be kept to a minimum and laid out as simply as possible. Each table should be typed on a separate sheet, numbered in Arabic numerals, and not duplicate information in the text. Footnotes for tables are to be indicated by superscript lowercase letters or by asterisks for significance values and other statistical data.Figures should be cited in the text and numbered sequentially with Arabic numerals. Lowercase roman letters are to be used to identify figure parts. (a, b, etc.).If illustrations are supplied with uppercase labeling, lowercase letters will still be used in the figure legends and citations. A brief descriptive legend should be provided for each figure; legends are part of the text and should be appended to it on a separate page. The top of the figure and the figure number should be indicated. Also to be included are the magnification of photomicrographs as well as the details of staining techniques involved (e.g. H & E; × 100). The figures must match the size of either the column width (8.4 cm) or the printing area (17.4 × 23.4 cm). Related figures should be grouped into a plate on one page (17.4 × 23.4 cm). If plates are submitted, the figure numbers are to appear on the artwork. The figures, including legends, cannot exceed the printing area.Color illustrations will be accepted; Online publication of color illustrations is free of charge. For color in the print version, however, the authors will be expected to make a contribution to the extra cost (JPY 110 000 for the first color page and JPY 60 000 for each additional color page). Line drawings: The inscriptions must be clearly legible. Computer drawings are acceptable provided their quality is comparable to that of line drawings. Computer-drawn curves and lines should be smooth. Letters (uppercase) 2 mm high are recommended. Halftone illustrations: well-contrasted photographic prints, trimmed at right angles. Inscriptions height about 3 mm.If reduction is absolutely necessary, please state the alternative scale desired. The publisher reserves the right to reduce or enlarge illustrations.
NomenclatureNomenclature
Authors are referred to: Chemical Abstracts (Chemical Abstracts Service, Ohio State University) and The Merck Index (11th ed. 1989; Merck & Co., Inc.) for chemical and biological names; the International Code of Nomenclature of Bacteria and the Approved Lists of Bacterial Names (amended edition, American Society for Microbiology, Washington D.C.); The Yeasts: a Taxonomic Study (3rd ed. NJW Kregervan Riji, Elsevier Science Publishers B.V., Amsterdam, 1984), and Ainsworth and Bisby’s Dictionary of the Fungi, Including the Lichens (6th ed., Commonwealth Mycological Institute, Kew, Surrey, England, 1971) for fungal names, although the classification of fungi is not complete; and to recommendations from The International Committee on Nomenclature of Viruses for viral names and their classification.
AbbreviationsAbbreviations
A limited number of abbreviations, listed at the end of these instructions, can be used without definition. For other terms, define at first mention in the abstract and in the main body of the text, and use consistently thereafter.
List of Abbreviations
Case reportsCase reports
Case reports should be relevant to medical practice in the fields of infection and chemotherapy and are to be presented as concisely as possible. References should be kept to an absolute minimum. In Case reports, the arrangement of the text is as follows:(1) Abstract, (2) Introduction, (3) Case Report, (4) Discussion.
NotesNotes
Notes should be concise, not exceeding two to four printed pages (ten A4 double-spaced pages), with an abstract, up to 15 references, and three tables and/or figures. Do not use section headings in the body of the paper.
Letters to the EditorLetters to the Editor
Questions or comments concerning recently published papers should be sent to the Editor, who will refer them to the authors. The questions and authors�replies may subsequently be published together.
Review articlesReview articles
Review articles are in principle solicited by the Editorial Committee.
Committee reportsCommittee reports
Committee reports from any organization concerned with medical practice or research in the fields of infection and chemotherapy will be considered for publication.
GuidelinesGuidelines
Guidelines for medical practice, clinical examinations, or experiments in the fields of infection and chemotherapy will be considered for publication.
Expedited reviews of manuscriptsExpedited reviews of manuscripts
Reviews of manuscripts by the Editorial Committee may be accelerated on an exceptional basis when publication, if approved, would be urgent—for instance, for an author for whom the completion of an academic degree depends on publication of a submitted paper. In such cases, the author must include a covering letter stating the specific reasons for the request to accelerate the review process. If the quicker review is undertaken, the author will be expected to contribute any extra costs that may be incurred.
AddressAddress
Address all submissions and editorial communications, including books for review, to the Editor-in-Chief, Journal of Infection and Chemotherapy Editorial Office, c/o Springer Japan KK, No. 2 Funato Bldg., 1-11-11 Kudan-Kita, Chiyodaku, Tokyo 102-0073, Japan. Tel.: +81-3-6831-7009, Fax: +81-3-6831-7010. e-mail: jic@springer.jp
ProofreadingProofreading
Authors are informed by e-mail that a temporary URL has been created from which they can obtain their proofs.The purpose of the proof is to check for typesetting errors and the completeness and accuracy of the text, tables, and figures. Substantial changes in content, e.g., new results, corrected values, title, and authorship, are not allowed without the approval of the Editor.
OffprintsOffprints
Authors receive one complimentary copy of the issue in which their article appears. Offprints in lots of 100 at actual cost may be ordered by filling out the form included in the proof.
Open ChoiceOpen Choice
In addition to the normal publication process (whereby an article is submitted to the journal and access to that article is granted to customers who have purchased a subscription), Springer now provides an alternative publishing option: Springer Open Choice. A Springer Open Choice article receives all the benefits of a regular subscription-based article, but in addition is made available publicly through Springer’s online platform SpringerLink. We regret that Springer Open Choice cannot be ordered for already published articles. For further information, see Springer Open Choice at http://springer.com/openchoice.
Copyright transferCopyright transfer
Authors will be asked to transfer copyright of their articles to the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. This will ensure the widest possible protection and dissemination of information under copyright laws. Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, authors agree to the Springer Open Choice License.
Online FirstOnline First An article will be published online after receipt of the corrected proofs.This is the official first publication citable with the DOI. After release of the printed version, the article can also be cited by issue and page numbers. After online publication, further changes can be made only in the form of an Erratum, which will be hyperlinked to the article.
Editorial Board
Editorial Board
Editors-in-Chief Emeritus
Masatoshi Konno, MD, PhD
Professor Emeritus, Department of Clinical Pathology
Teikyo University, School of Medicine, Tokyo, Japan
Joichi Kumazawa, MD, PhD
Professor Emeritus, Department of Urology
Kyushu University, Faculty of Medicine, Fukuoka, Japan
Hiroyuki Kobayashi, MD, PhD
Professor Emeritus, Department of Internal Medicine I
Kyorin University School of Medicine, Tokyo, Japan
Keizo Yamaguchi, MD, PhD
Professor, Department of Microbiology
Toho University School of Medicine, Tokyo, Japan
Matsuhisa Inoue, PhD
Professor, Department of Microbiology
Kitasato University School of Medicine, Kanagawa, Japan
Kyoichi Totsuka, MD, PhD
Professor, Department of Infectious Diseases
Tokyo Women's Medical University, Tokyo, Japan
Seiji Hori, MD, PhD
Professor, Department of Pharmacology
Jikei University School of Medicine, Tokyo, Japan
Editor-in-Chief
Yoshio Kobayashi, MD, PhD
Assistant Professor, Department of Medicine
Keio University, Tokyo, Japan
Associate Editors
Satoshi Iwata
Shigeru Kamiya
Shin Kawai
Akihiko Kawana
Toshio Kishimoto
Hiroshi Kiyota
Shinya Kusachi
Tetsuya Matsumoto
Hiroko Nigorikawa
Kenji Ohnishi
Jun Okada
Hiroko Sagara
Hiromu Takemura
Mayumi Tanaka
Editorial Board
Keisuke Aiba
Hisanori Akiyama
Nobuki Aoki
Yasuko Aoki
Soichi Arakawa
Tetsuro Chimura
Takashi Deguchi
Takayuki Ezaki
Kozo Fujita
Hisashi Funada
Hajime Goto
Yuji Hanatani
Keiji Hirai
Keiichi Hiramatsu
Takaoki Hirose
Takeshi Honda
Hiroo Hoshino
Satoshi Ichiyama
Shu Ishikawa
Aikichi Iwamoto
Shizuko Iyobe
Junichi Kadota
Mitsuo Kaku
Katsuhiko Kamei
Akihiro Kaneko
Harushige Kanno
Motoshi Kawahara
Intetsu Kobayashi
Shigeru Kohno
Kazunari Kumasaka
Hiromi Kumon
Nobuchika Kusano
Gohta Masuda
Seiji Matsuda
Tetsuro Matsumoto
Hiroshige Mikamo
Keiichi Mikasa
Naoki Mitsuhashi
Shuichi Miyazaki
Takeshi Mori
Kazuhisa Murakami
Taiji Nakae
Tetsuya Nakamura
Katsuhisa Nakata
Issei Nakayama
Yoshihito Niki
Masayoshi Noguchi
Kazunori Oishi
Shinichi Oka
Kenji Okonogi
Shigeo Ono
Yasuo Ono
Shoichi Onodera
Tsuyoshi Otani
Kenichi Sato
Yoshitake Sato
Shiro Shigeta
Keisuke Sunakawa
Kanzo Suzuki
Hiroaki Takeda
Tsutomu Takeuchi
Yoshinao Takeuchi
Kazuhiro Tateda
Akiyoshi Tsuji
Kimiko Ubukata
Koichi Wada
Akira Watanabe
Haruo Watanabe
Kunitomo Watanabe
Yasuo Watanabe
Yoshinori Yamada
Naoki Yamamoto
Nobuhisa Yamane
Hiroki Yamaue
Hiroaki Yoshida
Tadashi Yoshida
International Advisory Board
Yunsop Chong, PhD
Professor, Section of Clinical Microbiology, Department of Clinical Pathology,
Yonsei University College of Medicine, Seoul, Korea
Paul H Edelstein, MD
Professor, Department of Pathology and Laboratory Medicine,
University of Pennsylvania Medical Center, Philadelphia, PA, USA
David C. Hooper, MD
Associate Professor, Division of Infectious Disease,
Massachusetts General Hospital, Boston, MA, USA
Robert C Moellering, Jr, MD
Professor, Harvard Medical School; Chairman, Department of Medicine,
Beth Israel Deaconess Medical Center, Boston, MA, USA
S. Ragnar Norrby, MD, PhD
Professor, Department of Infectious Diseases and Medical Microbiology,
Division of Infectious Diseases, University of Lund, Lund, Sweden
David S Reeves, MD
Medical Director/Consultant Medical Microbiologist,
Southmead Hospital, Bristol, UK
Thelma E Tupasi, MD
Department of Infectious Diseases, Makati Medical Center,
Metro Manila, Philippines
John Turnidge, MD
Director, Department of Microbiology and Infectious Diseases,
Women's and Children's Hospital, North Adelaide, South Australia, Australia
Jan Verhoef, MD, PhD
Director, Eijkman-Winkler Institute for Medical Infectious Diseases and Inflammation,
AZU, Utrecht, The Netherlands
Usman Chatib Warsa, MD, PhD
Department of Medical Microbiology, Faculty of Medicine,
University of Indonesia, Indonesia
Ying Yuan Zhang, MD
Institute of Antibiotics Hua Shan Hospital, Shanghai, China
|
